Early research (Phase 1)Study completedNCT00861406What this trial is testingAdjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide VaccineWho this might be right forMelanoma M.D. Anderson Cancer Center 38
Early research (Phase 1)Study completedNCT02375256What this trial is testingA Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402Who this might be right forTuberculosis Aeras 11
Testing effectiveness (Phase 2)Study completedNCT00040482What this trial is testingHigh Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis Baylor College of Medicine 10
Early research (Phase 1)Study completedNCT01097590What this trial is testingEvaluate a Leukapheresis Treatment in Patients With Ulcerative ColitisWho this might be right forUlcerative Colitis IBD Column Therapies International AB 23
Not applicableLooking for participantsNCT00571389What this trial is testingA Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.Who this might be right forSolid Tumor, AdultHealthy DonorsCOVID-19 Donors BioCytics, Inc. 1,500
Not applicableEnded earlyNCT00316069What this trial is testingStem Cell CollectionWho this might be right forStem Cells National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 429
Not applicableLooking for participantsNCT07491328What this trial is testingLiquid Biopsy in Paraneoplastic Neurological SyndromesWho this might be right forParaneoplastic Neurological Syndromes Heinrich-Heine University, Duesseldorf 60
Not applicableLooking for participantsNCT04981119What this trial is testingSolid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingWho this might be right forSolid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more A2 Biotherapeutics Inc. 500
Early research (Phase 1)Not Yet RecruitingNCT07672483What this trial is testingIL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid TumorsWho this might be right forRelapsed Solid Tumor MalignanciesRefractory Solid Tumor Malignancies National Cancer Institute (NCI) 95
Not applicableEnded earlyNCT00001349What this trial is testingApheresis to Obtain Plasma or White Blood Cells for Laboratory StudiesWho this might be right forLeukopheresisPlasmapheresis National Institute of Allergy and Infectious Diseases (NIAID) 205
Testing effectiveness (Phase 2)Study completedNCT03657966What this trial is testingDCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian CancerWho this might be right forOvarian Cancer Recurrent SOTIO a.s. 33
Testing effectiveness (Phase 2)UnknownNCT00131560What this trial is testingSafety and Efficacy of T Cell Genetic Immunotherapy for HIVWho this might be right forHIV Infection VIRxSYS Corporation 60
Testing effectiveness (Phase 2)WithdrawnNCT04817345What this trial is testingPeripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using PlerixaforWho this might be right forSickle Cell Disease St. Jude Children's Research Hospital
Very early researchStudy completedNCT03175380What this trial is testingBiological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the USWho this might be right forTuberculosis Aeras 15
Large-scale testing (Phase 3)Study completedNCT00040235What this trial is testingMagnesium Effects in ApheresisWho this might be right forHealthy National Institutes of Health Clinical Center (CC) 52
Testing effectiveness (Phase 2)Looking for participantsNCT02015013What this trial is testingHematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine ModelsWho this might be right forIdiopathic CD4-PositiveT-Lymphocytopenia National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Looking for participantsNCT05003895What this trial is testingGPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor MalignanciesWho this might be right forHepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT03610724What this trial is testingPhase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma PatientsWho this might be right forNon-Hodgkin Lymphoma Novartis Pharmaceuticals 34
Early research (Phase 1)Study completedNCT00011830What this trial is testingStem Cell Mobilization Potential in Patients With Aplastic Anemia in RemissionWho this might be right forAplastic Anemia National Heart, Lung, and Blood Institute (NHLBI) 20
Early research (Phase 1)Study completedNCT01416974What this trial is testingConsolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and RituximabWho this might be right forLeukemia Memorial Sloan Kettering Cancer Center 13